Eli Lilly & Co. vs. Syndax Pharmaceuticals, Inc.
Eli Lilly & Co. and Syndax Pharmaceuticals, Inc. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| LLY | SNDX | |
|---|---|---|
| Market Cap | $1.12 trillion | $1.15 billion |
LLY leads on 1 of 1 size & scale factors.
Dividend
| LLY | SNDX | |
|---|---|---|
| Dividend Yield | 0.55% | — |
LLY and SNDX split the dividend factors evenly.
Risk & Sentiment
| LLY | SNDX | |
|---|---|---|
| Short Interest | 1.29% | 1.18% |
SNDX leads on 1 of 1 risk & sentiment factors.
Dig deeper: LLY overview, LLY financials, SNDX overview, SNDX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.